Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Controlled Release

• Publication date

  2010-07-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2010.03.017PMID 20359510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical evaluation of a single‐wavelength fractional laser and a novel multi‐wavelength fractional laser in the treatment of photodamaged skin

  2009cited by this paper
• Enhancement of Topical Small Interfering RNA Delivery and Expression by Low-Fluence Erbium:YAG Laser Pretreatment of Skin

  2009cited by this paper
• Porphyrin distribution after topical aminolevulinic acid in a novel porcine model of sebaceous skin

  2009cited by this paper
• Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.

  2008cited by this paper
• Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).

  2008cited by this paper
• Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy.

  2008cited by this paper
• Histologic and ultrastructural analysis of melasma after fractional resurfacing

  2008cited by this paper
• Laser treatments on skin enhancing and controlling transdermal delivery of 5‐fluorouracil

  2008cited by this paper
• Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy

  2008cited by this paper
• Fluorescence detection of protoporphyrin IX in living cells: a comparative study on single- and two-photon excitation.

  2008cited by this paper
• Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.

  2008cited by this paper
• Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.

  2007cited by this paper
• Fractional Photothermolysis: Treatment of Facial and Nonfacial Cutaneous Photodamage with a 1,550‐nm Erbium‐Doped Fiber Laser

  2007cited by this paper
• Liquid chromatography assay for 5-aminolevulinic acid: application to in vitro assessment of skin penetration via Dermaportation.

  2007cited by this paper
• Aminolevulinic acid photodynamic therapy for skin cancers.

  2007cited by this paper
• The prevalence and risk factors of post‐inflammatory hyperpigmentation after fractional resurfacing in Asians

  2007cited by this paper
• Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics

  2007cited by this paper
• Topical treatment with thiazolidinediones, activators of peroxisome proliferator‐activated receptor‐γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model

  2006cited by this paper
• In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.

  2006cited by this paper
• Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.

  2006cited by this paper
• Histologic effects of laser-assisted topical anesthesia in a porcine model.

  2005cited by this paper
• The correlation between transepidermal water loss and percutaneous absorption: an overview.

  2005cited by this paper
• The Treatment of Melasma with Fractional Photothermolysis: A Pilot Study

  2005cited by this paper
• Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation.

  2005cited by this paper
• The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum.

  2005cited by this paper
• In vitro and ex vivo protoporphyrin IX expression induced by 5-aminolevulinic acid in human pilosebaceous unit.

  2005cited by this paper
• Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin.

  2005cited by this paper
• Drug Delivery of Aminolevulinic Acid from Topical Formulations Intended for Photodynamic Therapy ¶

  2005cited by this paper
• Drug Delivery of Aminolevulinic Acid from Topical Formulations Intended for Photodynamic Therapy¶

  2005cited by this paper
• Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury

  2004cited by this paper
• Transdermal delivery of macromolecules by erbium:YAG laser.

  2004cited by this paper
• Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters.

  2004cited by this paper
• Transdermal drug delivery with a pressure wave.

  2004cited by this paper
• Lasers and microdermabrasion enhance and control topical delivery of vitamin C.

  2003cited by this paper
• Optimization of aminolevulinic acid delivery by iontophoresis.

  2003cited by this paper
• Ultrastructural evidence of stratum corneum permeabilization induced by photomechanical waves.

  2003cited by this paper
• Comparative in vitro percutaneous penetration of 5‐aminolevulinic acid and two of its esters through excised hairless mouse skin

  2003cited by this paper
• Designing for topical delivery: Prodrugs can make the difference

  2003cited by this paper
• Maximizing benefits and minimizing risk with CO2 laser resurfacing.

  2002cited by this paper
• In vitro/in vivo correlations between transdermal delivery of 5‐aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation

  2002cited by this paper
• Efficacy of erbium:yttrium-aluminum-garnet laser-assisted delivery of topical anesthetic.

  2002cited by this paper
• Self-adhesive thin films for topical delivery of 5-aminolevulinic acid.

  2002cited by this paper
• Er:YAG laser skin resurfacing.

  2002cited by this paper
• Photomechanical transdermal delivery: The effect of laser confinement

  2001cited by this paper
• Potential and problems of developing transdermal patches for veterinary applications.

  2001cited by this paper
• A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.

  2001cited by this paper
• Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system.

  2000cited by this paper
• Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives

  2000cited by this paper
• Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate.

  1999cited by this paper
• lontophoretic Permselectivity of Mammalian Skin: Characterization of Hairless Mouse and Porcine Membrane Models

  1998cited by this paper
• Confocal fluorescence microscopy (CFM) of 5′-aminolevulinic acid (ALA)-induced protoporphyrin IX (PPIX) in human squamous and Barrett's esophagus*

  1998cited by this paper
• Scanning electron microscopic evaluation of the skin surface after ultrasound exposure

  1997cited by this paper
• Photobleaching during and re‐appearance after photodynamic therapy of topical ALA‐induced fluorescence in UVB‐treated mouse skin

  1997cited by this paper
• Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin.

  1997cited by this paper
• Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study.

  1995cited by this paper
• Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.

  1992cited by this paper
• Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

  1990cited by this paper
• Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin

  1990cited by this paper
• Presence of intact intercellular lipid lamellae in the upper layers of the stratum corneum.

  1987cited by this paper
• ©1999 Cancer Research Campaign Article no. bjoc.1998.0255

  year unknowncited by this paper

• Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis

  2025cites this paper
• The Impacts of Non-Surgical Aesthetics on the Core Functional Triad of Skin

  2025cites this paper
• Laser-assisted delivery of imiquimod in Brooke-Spiegler syndrome

  2022cites this paper
• Aplicação de imiquimode associada a laser na síndrome de Brooke‐Spiegler

  2022cites this paper
• A clinical study of carbon dioxide lattice laser–assisted or microneedle‐assisted 5‐aminolevulinic acid–based photodynamic therapy for the treatment of hypertrophic acne scars

  2021cites this paper
• Combination of Laser Therapy and Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Cheilitis

  2021cites this paper
• Laser irradiation of ocular tissues to enhance drug delivery.

  2021cites this paper
• Topical delivery of PD‐1 inhibitors with laser‐assisted passive diffusion and active intradermal injection: Investigation of cutaneous pharmacokinetics and biodistribution patterns

  2021cites this paper
• Effectiveness and safety of ablative fractional CO2 laser for the treatment of burn scars: A case-control study.

  2020cites this paper
• Human Fibroblast-derived Multi-peptide Factors and the Use of Energy-delivering Devices in Asian Patients

  2020cites this paper
• Laser management of hypertrophic burn scars: a comprehensive review

  2020cites this paper
• New Developments for Fractional Co2 Resurfacing for Skin Rejuvenation and Scar Reduction.

  2020cites this paper
• Fundamentals of fractional laser-assisted drug delivery: An in-depth guide to experimental methodology and data interpretation.

  2019cites this paper
• Effect of fractional ablative carbon dioxide laser with lidocaine spray on skin flap survival in rats

  2019cites this paper
• Laser ablation and topical drug delivery: a review of recent advances

  2019cites this paper
• Current Views on Melasma

  2018cites this paper
• Fraktionierte UltraPulse-CO 2 - Laserbehandlung schwerer Verbrennungsnarben

  2018cites this paper
• Application of water‐soluble polyvinyl alcohol‐based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery

  2018cites this paper
• The effect of pulse duration, power and energy of fractional Er:YAG laser for transdermal delivery of differently sized FITC dextrans.

  2017cites this paper
• Ablative fractional CO2 laser for burn scar reconstruction: An extensive subjective and objective short-term outcome analysis of a prospective treatment cohort.

  2017cites this paper
• Laser Modulation of Hypertrophic Scars: Technique and Practice.

  2017cites this paper
• Transcutaneous drug delivery by liposomes using fractional laser technology

  2017cites this paper
• Comparative analysis of the effects of CO2 fractional laser and sonophoresis on human skin penetration with 5-aminolevulinic acid

  2017cites this paper
• Transcutaneous drug delivery by liposomes using fractional laser technology(本文)

  2017cites this paper
• Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.

  2017cites this paper
• Laser‐induced thermal coagulation enhances skin uptake of topically applied compounds

  2017cites this paper
• Fractional laser-assisted percutaneous drug delivery via temperature-responsive liposomes

  2017cites this paper
• Laser‐assisted drug delivery: mode of action and use in daily clinical practice

  2016cites this paper
• Laser Microporation of Skin

  2016cites this paper
• Fractional Ablative Laser Followed by Transdermal Acoustic Pressure Wave Device to Enhance the Drug Delivery of Aminolevulinic Acid: In Vivo Fluorescence Microscopy Study.

  2016cites this paper
• Skin Pretreatment With Conventional Non-Fractional Ablative Lasers Promote the Transdermal Delivery of Tranexamic Acid

  2016cites this paper
• Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment.

  2016cites this paper
• Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status.

  2016cites this paper
• Ablative fractional laser enhances MAL-induced PpIX accumulation: Impact of laser channel density, incubation time and drug concentration.

  2016cites this paper
• Fractional laser‐assisted drug delivery: Active filling of laser channels with pressure and vacuum alteration

  2016cites this paper
• Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.

  2016cites this paper
• Laser assisted Drug Delivery: Grundlagen und Praxis

  2016cites this paper
• Femtosecond pulsed laser ablation to enhance drug delivery across the skin

  2016cites this paper
• Rapid fibrin plug formation within cutaneous ablative fractional CO2 laser lesions

  2016cites this paper
• Laser-assisted delivery of topical methotrexate - in vitro investigations.

  2016cites this paper
• Iontophoresis as a non-invasive enhancement technique for the administration of drugs across biological membranes

  2015cites this paper
• Ablative fractional laser alters biodistribution of ingenol mebutate in the skin

  2015cites this paper
• Fractional CO2 Laser Treatment to Enhance Skin Permeation of Tranexamic Acid with Minimal Skin Disruption

  2015cites this paper
• Shaving area of unwanted hair before laser operation is useful in cosmetic procedure: A simulation study

  2015cites this paper
• Fractional radiofrequency combined with sonophoresis to facilitate skin penetration of 5-aminolevulinic acid

  2015cites this paper
• Fractional laser‐mediated photodynamic therapy of high‐risk basal cell carcinomas – a randomized clinical trial

  2015cites this paper
• Laser Assisted Drug and Cosmeceutical Delivery System of the Skin

  2015cites this paper
• Laser assisted drug delivery: A review of an evolving technology

  2014cites this paper
• Convergence of anatomy, technology, and therapeutics: a review of laser-assisted drug delivers.

  2014cites this paper
• Impact of Different Vehicles for Laser-Assisted Drug Permeation via Skin: Full-Surface versus Fractional Ablation

  2014cites this paper
• Squarticles as a Lipid Nanocarrier for Delivering Diphencyprone and Minoxidil to Hair Follicles and Human Dermal Papilla Cells

  2014cites this paper
• Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser.

  2014cites this paper
• Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.

  2014cites this paper
• Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial

  2014cites this paper
• Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5‐aminolevulinic acid (ALA) and methyl aminolevulinate (MAL)

  2014cites this paper
• Efficacy of high‐intensity focused ultrasonography for noninvasive body sculpting in Chinese patients

  2014cites this paper
• Nonablative fractional laser as a tool to facilitate skin penetration of 5‐aminolaevulinic acid with minimal skin disruption: a preliminary study

  2014cites this paper
• Micro-fractional epidermal powder delivery for improved skin vaccination.

  2014cites this paper
• Lasers as an approach for promoting drug delivery via skin

  2014cites this paper
• Skin ablation by physical techniques for enhancing dermal/transdermal drug delivery

  2014cites this paper
• The use of fractionated ablative lasers as a transdermal microporation technique

  2013cites this paper
• Characterization of a newly isolated Rubrivivax benzoatilyticus PS-5 with self-flocculation property and optimization pathway for 5-aminolevulinic acid production

  2013cites this paper
• An update on the use of laser technology in skin vaccination

  2013cites this paper
• Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin.

  2013cites this paper
• Co-drug strategy for promoting skin targeting and minimizing the transdermal diffusion of hydroquinone and tranexamic acid.

  2013cites this paper
• Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines

  2013cites this paper
• Risk assessment of excess drug and sunscreen absorption via skin with ablative fractional laser resurfacing

  2013cites this paper
• Skin Permeation of Small-Molecule Drugs, Macromolecules, and Nanoparticles Mediated by a Fractional Carbon Dioxide Laser: The Role of Hair Follicles

  2013cites this paper
• Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook

  2013cites this paper
• Transdermal delivery of three vitamin C derivatives by Er:YAG and carbon dioxide laser pretreatment

  2013cites this paper
• Application of HPLC-ELSD for the Quantification of 5-Aminolevulinic Acid after Penetration into Human Skin Ex Vivo

  2013cites this paper
• Enhanced Topical Delivery of Small Hydrophilic or Lipophilic Active Agents and Epidermal Growth Factor by Fractional Radiofrequency Microporation

  2012cites this paper
• Fractional laser‐assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time

  2012influential citation
• Novel methods and devices to enhance transdermal drug delivery: the importance of laser radiation in transdermal drug delivery.

  2012cites this paper
• The impact of treatment density and molecular weight for fractional laser-assisted drug delivery.

  2012cites this paper
• Transdermal iontophoresis for the controlled delivery of therapeutic agents to treat neurodegenerative diseases

  2012cites this paper
• LASER MICROPORATION FOR THE DELIVERY OF DRUGS INTO AND ACROSS THE SKIN

  2012cites this paper
• Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.

  2012cites this paper
• Fractional Carbon Dioxide Laser Treatment to Enhance Skin Permeation of Ascorbic Acid 2‐Glucoside with Minimal Skin Disruption

  2012cites this paper
• Transcutaneous vaccination via laser microporation

  2012cites this paper
• Evaluation of base for optimal drug delivery for iontophoretic therapy: Investigation of quality and stability

  2012cites this paper
• Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.

  2011cites this paper
• Enhancement techniques for improving 5-aminolevulinic acid delivery through the skin

  2011cites this paper
• Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions

  2011influential citation
• Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies.

  2011cites this paper
• Enhancement techniques for improving 5aminolevulinic 5aminolevulinic 5aminolevulinic acid delivery through the skin

  year unknowncites this paper